{"PubmedArticle": [{"MedlineCitation": {"SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "OtherAbstract": [], "CitationSubset": ["IM"], "KeywordList": [], "GeneralNote": [], "PMID": "18785039", "DateCompleted": {"Year": "2009", "Month": "03", "Day": "25"}, "DateRevised": {"Year": "2022", "Month": "12", "Day": "07"}, "Article": {"ArticleDate": [], "Language": ["eng"], "ELocationID": ["10.1080/03639040802258854"], "Journal": {"ISSN": "1520-5762", "JournalIssue": {"Volume": "35", "Issue": "2", "PubDate": {"Year": "2009", "Month": "Feb"}}, "Title": "Drug development and industrial pharmacy", "ISOAbbreviation": "Drug Dev Ind Pharm"}, "ArticleTitle": "Wax-matrix tablet for time-dependent colon-specific delivery system of sophora flavescens Aiton: preparation and in vivo evaluation.", "Pagination": {"StartPage": "224", "EndPage": "233", "MedlinePgn": "224-33"}, "Abstract": {"AbstractText": ["A wax-matrix time-dependent colon-specific tablet (WM-TDCS) was studied. Wax-matrix tablet core consisting of semi-synthetic glycerides, as a wax polymeric expanding agent, carboxymethyl starch sodium (CMS-Na), and NaCl was prepared, and Sophora flavescens Aiton (ASF, extracts of traditional Chinese medicine) was used as model drug. The wax-matrix ASF tablets core was coated with Eudragit NE 30 D as the inner coating materials and with Opadry OY-P-7171 as the outer coating materials. The in vitro release behaviors of the coated tablets were examined and then in vivo absorption kinetics of the coated tablets in dogs was further investigated. The volume of the tablet core was markedly increased at 37 degrees C because of the expand effect of polymer semi-synthetic glycerides and CMS-Na. The drug release from WM-TDCS was more stable than TDCS in vitro and in vivo. The lag time of ASF release was also controlled by the thickness of the inner coating layer. In vivo evaluation demonstrated that in vivo lag time of absorption was in a good agreement with in vitro lag time of release. ASF wax-matrix tablets coated with Eudragit NE 30 D and Opadry OY-P-7171 using the regular coating technique could be designed to achieve a lag time of 3 h in the small intestinal tract."]}, "AuthorList": [{"AffiliationInfo": [{"Identifier": [], "Affiliation": "School of Pharmacy, Shenyang Pharmaceutical University, Shenyang, P.R. China."}], "Identifier": [], "LastName": "Zou", "ForeName": "Meijuan", "Initials": "M"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Wang", "ForeName": "Yue", "Initials": "Y"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Xu", "ForeName": "Caihong", "Initials": "C"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Cheng", "ForeName": "Gang", "Initials": "G"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Ren", "ForeName": "Jungang", "Initials": "J"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Wu", "ForeName": "Gaolei", "Initials": "G"}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "England", "MedlineTA": "Drug Dev Ind Pharm", "NlmUniqueID": "7802620", "ISSNLinking": "0363-9045"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Alkaloids"}, {"RegistryNumber": "0", "NameOfSubstance": "Delayed-Action Preparations"}, {"RegistryNumber": "0", "NameOfSubstance": "Drug Combinations"}, {"RegistryNumber": "0", "NameOfSubstance": "Drugs, Chinese Herbal"}, {"RegistryNumber": "0", "NameOfSubstance": "Eudragit NE 30-D"}, {"RegistryNumber": "0", "NameOfSubstance": "Glycerides"}, {"RegistryNumber": "0", "NameOfSubstance": "Methacrylates"}, {"RegistryNumber": "0", "NameOfSubstance": "Polymers"}, {"RegistryNumber": "0", "NameOfSubstance": "Quinolizines"}, {"RegistryNumber": "0", "NameOfSubstance": "Tablets, Enteric-Coated"}, {"RegistryNumber": "0", "NameOfSubstance": "Waxes"}, {"RegistryNumber": "451W47IQ8X", "NameOfSubstance": "Sodium Chloride"}, {"RegistryNumber": "85U4C366QS", "NameOfSubstance": "oxymatrine"}, {"RegistryNumber": "9005-25-8", "NameOfSubstance": "Starch"}, {"RegistryNumber": "9057-06-1", "NameOfSubstance": "carboxymethyl starch"}, {"RegistryNumber": "0", "NameOfSubstance": "Matrines"}], "MeshHeadingList": [{"QualifierName": ["analysis"], "DescriptorName": "Alkaloids"}, {"QualifierName": [], "DescriptorName": "Animals"}, {"QualifierName": ["metabolism"], "DescriptorName": "Colon"}, {"QualifierName": [], "DescriptorName": "Delayed-Action Preparations"}, {"QualifierName": [], "DescriptorName": "Dogs"}, {"QualifierName": [], "DescriptorName": "Drug Combinations"}, {"QualifierName": [], "DescriptorName": "Drug Compounding"}, {"QualifierName": [], "DescriptorName": "Drug Delivery Systems"}, {"QualifierName": ["administration & dosage", "metabolism"], "DescriptorName": "Drugs, Chinese Herbal"}, {"QualifierName": [], "DescriptorName": "Glycerides"}, {"QualifierName": [], "DescriptorName": "Hydrogen-Ion Concentration"}, {"QualifierName": [], "DescriptorName": "Intestinal Absorption"}, {"QualifierName": [], "DescriptorName": "Male"}, {"QualifierName": [], "DescriptorName": "Methacrylates"}, {"QualifierName": ["chemistry"], "DescriptorName": "Plants, Medicinal"}, {"QualifierName": [], "DescriptorName": "Polymers"}, {"QualifierName": ["analysis"], "DescriptorName": "Quinolizines"}, {"QualifierName": [], "DescriptorName": "Sodium Chloride"}, {"QualifierName": ["chemistry"], "DescriptorName": "Sophora"}, {"QualifierName": ["analogs & derivatives"], "DescriptorName": "Starch"}, {"QualifierName": [], "DescriptorName": "Tablets, Enteric-Coated"}, {"QualifierName": [], "DescriptorName": "Waxes"}, {"QualifierName": [], "DescriptorName": "Matrines"}]}, "PubmedData": {"ReferenceList": [], "History": [{"Year": "2008", "Month": "9", "Day": "12", "Hour": "9", "Minute": "0"}, {"Year": "2009", "Month": "3", "Day": "26", "Hour": "9", "Minute": "0"}, {"Year": "2008", "Month": "9", "Day": "12", "Hour": "9", "Minute": "0"}], "PublicationStatus": "ppublish", "ArticleIdList": ["18785039", "10.1080/03639040802258854", "902384674"]}}], "PubmedBookArticle": []}